Skip to content

Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)

Outcomes of Blood Flow Restriction Training on the Ulnar Collateral Ligament

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06664827
Enrollment
50
Registered
2024-10-30
Start date
2025-01-16
Completion date
2028-11-30
Last updated
2025-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Healthy Male and Female Subjects, Healthy Volunteers

Brief summary

The goal of this clinical trial is to identify any differences in elbow ulnar collateral ligament (UCL) relative thickness and joint space laxity in the dominant arm following an 8-week course of low intensity resistance exercises with blood flow restriction (BFR) exercises in healthy volunteers. The main questions it aims to answer are: 1. Do BFR exercises contribute to a change in the relative ligament thickness of the UCL, and changes in the ulnohumeral joint space? 2. Are there changes in arm strength following the 8-week strengthening protocol with/without BFR? Participants will: * Complete two BFR sessions a week for a total of eight weeks. * Complete an exercise session with both arms (dominant arm will receive BFR) at each study visit. * Have sonographs taken of the UCL at the first and last study visit. * Complete strength assessments at the first and last study visit.

Interventions

DEVICEDelfi PTS Blood Flow Restriction Tourniquet System

In Houston Methodist rehabilitation clinics these devices are used as standard of care for BFR therapy in many post-operative treatments. General guidelines suggest using ranges between 30% - 80% of limb occlusion pressure (LOP). In our previous research efforts involving BFR the investigators have adhered to these guidelines and experienced no adverse events while observing these ranges to be well tolerated by subjects.

Sponsors

The Methodist Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteer * Agree to complete all exercise sessions and program in its entirety * Between the ages of 18-50 years old

Exclusion criteria

* Current or recent injury of the hand, elbow, or shoulder * Outside of the ages of 18-50 years old * Vascular compromise or previous vascular surgery * History of DVT * Current participation in other BFR research study * Currently participating in a structured strength training program * Any musculoskeletal conditions resulting in inability to exercise * Participants may not be collegiate/professional baseball/softball players * Vulnerable populations

Design outcomes

Primary

MeasureTime frameDescription
Relative ligament thickness of the UCLFrom baseline visit to end of treatment at 8 weeksLigament thickness will be evaluated by ultrasound imaging measurement.
Changes in the ulnohumeral joint laxityAt baseline visit and end of treatment at 8 weeksAny changes will be evaluated by ultrasound imaging. To calculate the relative measurement, also known as the side-to-side difference (STS), investigators will take measurements from both the dominant and nondominant arms and then calculate difference between the two.

Secondary

MeasureTime frameDescription
Changes in arm strengthFrom baseline visit to end of treatment at 8 weeksThis value will be measured with a crane scale (a device used to measure force) and will evaluate the participant's maximum force output with different movements. Higher or lower scores don't reflect whether an outcome is better or worse, but rather each participant's scores are only being compared to their own to assess strength change.

Countries

United States

Contacts

Primary ContactHaley Goble, MHA
hmgoble@houstonmethodist.org713-441-3930

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026